Godavari Biorefineries Secures US Patent for Novel Cancer-Treatment Compounds
Godavari Biorefineries Ltd receives a US patent for a novel class of compounds targeting breast and prostate cancer, as trials for MSP008-22 start in Q3 FY27.
ALFA News
Straight from the exchange filing
Latest Godavari Biorefineries Ltd stock news from NSE and BSE filings, 3 stories so far.
Godavari Biorefineries Ltd receives a US patent for a novel class of compounds targeting breast and prostate cancer, as trials for MSP008-22 start in Q3 FY27.